Our previous studies illuminated that loss of MD1, a negative physiological regulator of the TLR4 signaling pathway, could worsen cardiac structural and electrical remodeling in a pathological condition, such as hypertrophic cardiomyopathy and ischemia/reperfusion injury [6,8]. Here, TLR4 is linked to hypertrophic cardiomyopathy.